Survivorship & Long-Term Monitoring

Managing Castleman disease (CD) is often more of a marathon than a sprint. While achieving “stable disease” or “remission” is the primary goal, life after diagnosis involves a new routine of monitoring, managing treatment effects, and staying vigilant for changes in your body ^[1][2].

Recognizing and Monitoring a “Flare”

In Multicentric Castleman disease (MCD), the disease can cycle between periods of quiet (remission) and periods of activity, often called a flare.

• The Warning Signs: A flare is essentially your immune system “re-igniting.” You may notice the return of “flu-like” symptoms such as night sweats, unexplained fevers, or profound fatigue ^[3][4].
• The Biomarker “Signature”: Your doctor will use blood tests to track your C-reactive protein (CRP) and hemoglobin. For many patients, a rise in CRP is the earliest biological sign that a flare is starting, sometimes appearing before you even feel sick ^[5][6]. Knowing your “healthy baseline” for these markers is essential for early detection.

Life on Chronic Therapy

Many patients with iMCD remain on anti-IL-6 therapy (like siltuximab) for years, or even lifelong, to keep the disease in check.

• Long-Term Safety: Research shows that siltuximab is generally well-tolerated over long periods (up to 7 years and beyond) without evidence of “cumulative toxicity” (damage that builds up over time) ^[1][7].
• Managing Side Effects: While generally safe, these medications can slightly increase your risk of infections. It is important to stay current on non-live vaccinations and report any signs of illness (even a minor cold or skin infection) to your hematologist immediately ^[7][8].
• Crucial Vaccine Warning: If you are on immunosuppressive therapies like siltuximab or rituximab, you must strictly avoid live attenuated vaccines (such as MMR or Yellow Fever). Receiving a live vaccine while immunosuppressed can cause a severe, life-threatening infection. Always consult your hematologist before receiving any new vaccine ^[7].
• Chronic Fatigue: Many survivors deal with lingering fatigue even when their labs look “normal.” Managing this often requires a multidisciplinary approach, including gentle exercise and pacing your daily activities ^[4].

Coping with “Scanxiety”

Routine imaging (PET/CT or CT scans) is a standard part of long-term monitoring to ensure lymph nodes aren’t growing. The stress of waiting for these scans and results is often called scanxiety ^[9][10].

• Strategies for Peace of Mind: To manage this stress, ask your clinic to schedule your “results appointment” as close to the scan time as possible ^[10][11]. Focus on “present-moment” coping rather than anticipating the “what-ifs” of the results ^[12][13].

Your Data as a Tool: The ACCELERATE Registry

Because Castleman disease is so rare, every single patient’s experience is a vital piece of the puzzle. The ACCELERATE registry is a global database managed by the Castleman Disease Collaborative Network (CDCN) ^[14].

• Why it Matters: By contributing your de-identified medical records to ACCELERATE, you are helping researchers identify which treatments work best for specific subtypes. This registry has been a primary source for the current international treatment guidelines you are following today ^[14][15]. Participation empowers you to turn your personal journey into progress for the entire CD community.

Summary Checklist for Long-Term Health

• [ ] Know Your Baselines: Keep a record of your CRP, hemoglobin, and albumin levels when you are feeling well ^[5].
• [ ] Track Your “Signature” Symptoms: Note any recurring symptoms that seem to precede a flare.
• [ ] Stay Vigilant: Report any new fevers or infections immediately while on immune-modulating therapy ^[7].
• [ ] Contribute to Research: Join the CDCN and enroll in the ACCELERATE registry to help drive future breakthroughs ^[14].